haloperidol has been researched along with butaclamol in 85 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 47 (55.29) | 18.7374 |
1990's | 19 (22.35) | 18.2507 |
2000's | 8 (9.41) | 29.6817 |
2010's | 8 (9.41) | 24.3611 |
2020's | 3 (3.53) | 2.80 |
Authors | Studies |
---|---|
Bruderlein, FT; Humber, LG; Voith, K | 1 |
Ellefson, CR; Kehr, JR; Miller, A; Woo, CM | 1 |
George, SR; Guan, HC; Laurier, LG; Ng, G; Niznik, HB; O'Dowd, BF; Seeman, P; Sunahara, RK; Torchia, J; Van Tol, HH | 1 |
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Harbert, CA; Koe, BK; Weissman, A; Welch, WM | 1 |
New, JS; Riblet, LA; Taylor, DP; Temple, DL; Yevich, JP | 1 |
Berardi, F; Colabufo, NA; Fiorentini, F; Ghiglieri, A; Govoni, S; Leopoldo, M; Olgiati, V; Perrone, R; Tortorella, V | 1 |
Demattos, S; MacKenzie, RG; O'Malley, KL; Pugsley, TA; Shih, YH; Tang, L; Todd, RD; VanLeeuwen, D | 1 |
Foulon, C; Kung, HF; Kung, MP | 1 |
Emms, F; Freedman, SB; Knowles, MR; Marwood, R; McAllister, G; Patel, S; Seabrook, GR | 1 |
Amlaiky, N; Hen, R; Plassat, JL | 1 |
Arrang, JM; Diaz, J; Leurs, R; Ruat, M; Schwartz, JC; Tardivel-Lacombe, J; Traiffort, E | 1 |
Audinot, V; Chaput, C; Conte, C; Gavaudan, S; Millan, MJ; Newman-Tancredi, A; Touzard, M; Verrièle, L | 1 |
Booth, RG; Brown, RL; Bucholtz, EC; Tropsha, A; Wyrick, SD | 1 |
Bienkowski, P; Bucki, A; Jaśkowska, J; Kazek, G; Kowalski, P; Kołaczkowski, M; Marcinkowska, M; Mierzejewski, P; Mitka, K; Pawłowski, M; Siwek, A; Wasik, A; Wesołowska, A | 1 |
Bienkowski, P; Bucki, A; Jastrzębska-Więsek, M; Kazek, G; Kołaczkowski, M; Marcinkowska, M; Mierzejewski, P; Partyka, A; Pawłowski, M; Siwek, A; Śniecikowska, J; Wasik, A; Wesołowska, A | 1 |
Bednarski, M; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pękala, E; Powroźnik, B; Słoczyńska, K; Walczak, M; Waszkielewicz, AM; Żesławska, E | 1 |
Alberts, IL; Gadhiya, S; Harding, WW; Kalidindi, T; Kurtzman, T; Madapa, S; Pillarsetty, NK; Ramsey, S | 1 |
Alberts, I; Harding, WW; Juarez, R; Karki, A; Namballa, HK | 1 |
Alberts, I; Giri, R; Harding, WW; Namballa, HK; Sarker, A | 1 |
Alberts, I; Harding, WW; Karki, A; Namballa, HK | 1 |
Ahern, DG; Filer, CN; Grigoriadis, D; Guan, JH; Lilly, L; Neumeyer, JL; Seeman, P; Watanabe, M | 1 |
Baldessarini, RJ; Booth, RG; Charifson, PS; Kula, NS; McPhail, AT; Myers, AM; Owens, CE; Wyrick, SD | 1 |
Berardi, F; Giudice, G; Govoni, S; Lucchi, L; Perrone, R; Tortorella, V | 1 |
Brasili, L; Costantino, L; Franchini, S; Gandolfi, F; Leonardi, A; Poggesi, E; Prezzavento, O; Ronsisvalle, G; Sorbi, C; Vittorio, F | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Altenbach, RJ; Brioni, JD; Carr, TL; Chandran, P; Cowart, MD; Esbenshade, TA; Honore, P; Hsieh, GC; Lewis, LG; Liu, H; Manelli, AM; Marsh, KC; Milicic, I; Miller, TR; Strakhova, MI; Vortherms, TA; Wakefield, BD; Wetter, JM; Witte, DG | 1 |
Hayashi, S; Kato, A; Mizuno, K; Morita, A; Nakata, E; Ohashi, K; Yamamura, K | 1 |
Anzini, M; Brogi, S; Butini, S; Campiani, G; Cappelli, A; Caselli, G; Castriconi, F; Gemma, S; Giordani, A; Giorgi, G; Giuliani, G; Lanza, M; Letari, O; Makovec, F; Manini, M; Mennuni, L; Valenti, S | 1 |
Belyakov, S; Dambrova, M; Kazoka, H; Kuznecovs, J; Lebedev, A; Liepinsh, E; Mishnev, A; Orlova, N; Ponomaryov, Y; Vavers, E; Veinberg, G; Vikainis, S; Vilskersts, R; Vorona, M; Zvejniece, L | 1 |
Bartenstein, P; Chowdhury, S; Djurova, P; Fricker, G; Höfner, G; Purisima, EO; Schirrmacher, R; Wängler, B; Wängler, C; Wanner, KT | 1 |
Goldstein, M; Hata, F; Lew, JY; Ohashi, T | 1 |
Jain, PC; Kumar, N | 1 |
Freed, WJ; Neckers, LM; Perlow, MJ; Rosenblatt, JE; Shore, D; Wyatt, RJ | 1 |
Bowles, J; Brown, GM; Chau-Wong, M; Friend, WC; Lee, T; McManus, C; Muller, P; Seeman, P; Tedesco, JL; Tittler, M; Weinreich, P; Whitaker, PM | 1 |
Seeman, P; Sinclair, D; Titeler, M; Weinreich, P | 1 |
Meltzer, HY; So, R | 1 |
Fujita, N; Saito, K; Watanabe, Y; Yonehara, N; Yoshida, H | 1 |
Klemm, N; Kuhar, MJ; Malouf, AT; Murrin, LC | 1 |
Boullin, DJ; Molyneux, D; Roach, B | 1 |
Miller, JC | 1 |
Benedetto, P; Feigenblum, D; Filer, D; Goldstein, M; Lew, JY; Tang, D; Zawadzka, H | 1 |
Barden, N; L'Héreault, S | 1 |
Crompton, S; Maxwell, G; Smyth, C | 1 |
Leitner, LM; Roumy, M | 1 |
Baines, AD; Drangova, R | 1 |
Friedhoff, AJ; Miller, JC | 1 |
Heyer, EJ | 1 |
Fowler, JS; Logan, J; Shiue, CY; Wolf, AP | 1 |
Ishikawa, T; Murakami, H; Sano, M | 1 |
Jenner, P; Marsden, CD; Rose, S; Weller, ME | 1 |
Blaha, CD; Lane, RF | 1 |
Carvalho, AP; Duarte, EP; Oliveira, CR | 1 |
Bigornia, L; Napp, D; Ryan, KA; Schneider, AS; Suozzo, M | 1 |
Liberini, P; Memo, M; Missale, C; Spano, P | 1 |
Fuchs, S; Kanety, H | 1 |
Balster, RL | 1 |
Iwamoto, ET | 1 |
Bissette, G; Dauer, WT; Kilts, CD; Nemeroff, CB; O'Connor, L | 1 |
Arnett, CD; Fowler, JS; Logan, J; Shiue, CY; Watanabe, M; Wolf, AP | 1 |
Madras, BK; Seeman, P | 1 |
Mott, J; Sherman, AD | 2 |
Denef, C; Dewals, R; Manet, D | 1 |
Gnegy, ME; Lau, YS | 1 |
Bacopoulos, NG | 1 |
Agrawal, AK; Bondy, SC | 1 |
Carlson, KR; Seeger, TF | 1 |
Luchins, DJ; Oliver, AP; Wyatt, RJ | 1 |
Dowling, JE; Van Buskirk, R | 1 |
Dowling, JE; Watling, KJ | 1 |
Marshall, JF; Neve, KA | 1 |
Agid, Y; Bokobza, B; Javoy-Agid, F; Montfort, JC; Ruberg, M | 1 |
Beuerman, RW; Crosson, CE; Klyce, SD | 1 |
MacKenzie, RG; Zigmond, MJ | 1 |
Chio, CL; Drong, RF; Gill, GS; Huff, RM; Riley, DT; Slightom, JL | 1 |
Gardner, B; Strange, PG | 1 |
Iida, Y; Iwasaki, Y; Konishi, J; Magata, Y; Saji, H; Tanahashi, K; Yokoyama, A; Yonekura, Y | 1 |
Amenta, F; Barili, P; Zaccheo, D | 1 |
Dewey, SL; Fowler, JS; Gatley, SJ; Logan, J; Schlyer, DJ; Shea, C; Volkow, ND; Wolf, AP; Yousef, KA | 1 |
Gálfi, M; Janáky, T; Juhász, A; László, FA; Prohászka, G; Tóth, R; Varga, C | 1 |
Fu, D; Javitch, JA; Lin, H; Strange, PG; Wilson, J | 1 |
Colpaert, FC; Pauwels, PJ; Tardif, S; Wurch, T | 1 |
Huang, XF; Zavitsanou, K | 1 |
Bastianetto, S; Danik, M; Mennicken, F; Quirion, R; Williams, S | 1 |
2 review(s) available for haloperidol and butaclamol
Article | Year |
---|---|
Agents acting on central dopamine receptors.
Topics: 2-Naphthylamine; Adenylyl Cyclases; Animals; Antipsychotic Agents; Apomorphine; Benzocycloheptenes; Binding Sites; Brain; Butaclamol; Butyrophenones; Dopamine; Extrapyramidal Tracts; Haloperidol; Humans; Indoles; Isoquinolines; Molecular Conformation; Neurons; Phenothiazines; Pyrazines; Receptors, Dopamine; Stereoisomerism; Structure-Activity Relationship; Synapses | 1977 |
Dopamine receptors in the central nervous system.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Butaclamol; Cattle; Central Nervous System; Dihydroergotoxine; Haloperidol; Lysergic Acid Diethylamide; Radioligand Assay; Receptors, Adrenergic; Receptors, Dopamine | 1978 |
83 other study(ies) available for haloperidol and butaclamol
Article | Year |
---|---|
Neuroleptics related to butaclamol. Synthesis and some psychopharmacological effects of a series of 3-aryl analogues.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Butaclamol; Catalepsy; Conditioning, Psychological; Dextroamphetamine; Dibenzocycloheptenes; Epinephrine; Humans; Male; Rats; Stereotyped Behavior; Structure-Activity Relationship | 1978 |
Synthesis and biological evaluation of some 2-amino-4-aryl-3H-1,5-benzodiazepine analogues of clozapine.
Topics: Adenylyl Cyclase Inhibitors; Animals; Antipsychotic Agents; Avoidance Learning; Brain; Clozapine; Corpus Striatum; Dextroamphetamine; Dibenzazepines; Dopamine; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Mice; Rats | 1978 |
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Blotting, Northern; Brain; Cell Line; Cell Membrane; Cloning, Molecular; Dopamine; Humans; Kinetics; Molecular Sequence Data; Molecular Weight; Oligonucleotide Probes; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D5; RNA, Messenger; Sequence Homology, Nucleic Acid; Transfection | 1991 |
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Neuroleptics from the 4a,9b-cis- and 4a,9b-trans-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole series. 2.
Topics: Animals; Antipsychotic Agents; Carbolines; Hydrogen Bonding; Molecular Conformation; Rats; Receptors, Dopamine; Structure-Activity Relationship | 1986 |
Buspirone analogues. 1. Structure-activity relationships in a series of N-aryl- and heteroarylpiperazine derivatives.
Topics: Animals; Anti-Anxiety Agents; Binding, Competitive; Buspirone; Corpus Striatum; Kinetics; Male; Models, Molecular; Molecular Conformation; Piperazines; Pyrimidines; Rats; Receptors, Dopamine; Spiperone; Structure-Activity Relationship | 1983 |
High affinity and selectivity on 5-HT1A receptor of 1-aryl-4-[1-tetralin)alkyl]piperazines. 2.
Topics: Animals; Chemical Phenomena; Chemistry, Physical; Guinea Pigs; Isomerism; Kinetics; Male; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Structure-Activity Relationship; Tetrahydronaphthalenes | 1995 |
Characterization of the human dopamine D3 receptor expressed in transfected cell lines.
Topics: Animals; Arachidonic Acid; Binding, Competitive; Cell Line; CHO Cells; Cloning, Molecular; Cricetinae; Cricetulus; Cyclic AMP; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Inositol Phosphates; Mice; Radioligand Assay; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetrahydronaphthalenes; Transfection | 1994 |
Synthesis of (R,S)-2'-trans-7-hydroxy-2-[N-n-propyl-N-(3'-iodo-2'- propenyl)-amino]tetralin (trans-7-OH-PIPAT): a new D3 dopamine receptor ligand.
Topics: Binding Sites; Dopamine Agents; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Salicylamides; Stereoisomerism; Tetrahydronaphthalenes | 1993 |
Expression and pharmacological characterization of the human D3 dopamine receptor.
Topics: Animals; Binding, Competitive; Cells, Cultured; CHO Cells; Cricetinae; Dopamine; Dopamine Antagonists; GTP-Binding Proteins; Guanine Nucleotides; Humans; Potassium Channels; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Recombinant Proteins; Second Messenger Systems; Sulpiride | 1994 |
Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase.
Topics: Adenylyl Cyclases; Amino Acid Sequence; Animals; Base Sequence; Brain; Cloning, Molecular; Cyclic AMP; DNA; Drosophila; Enzyme Activation; Humans; Intestinal Mucosa; Mice; Molecular Sequence Data; Myocardium; Receptors, Serotonin; Sequence Homology, Amino Acid; Serotonin Antagonists; Serotonin Receptor Agonists | 1993 |
Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation.
Topics: Amino Acid Sequence; Animals; Base Sequence; Blotting, Northern; Brain; CHO Cells; Cricetinae; Cyclic AMP; DNA; Genomic Library; Kinetics; Lysergic Acid Diethylamide; Mianserin; Molecular Sequence Data; Multigene Family; Oligodeoxyribonucleotides; Organ Specificity; Rats; Receptors, Serotonin; Restriction Mapping; Serotonin; Serotonin Receptor Agonists; Transfection | 1993 |
Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study.
Topics: Animals; Antipsychotic Agents; CHO Cells; Cricetinae; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Agents; Sulfur Radioisotopes | 1998 |
Synthesis, evaluation, and comparative molecular field analysis of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for histamine H(1) receptors.
Topics: Animals; Binding Sites; Binding, Competitive; Brain; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ligands; Models, Molecular; Pyrilamine; Radioligand Assay; Structure-Activity Relationship; Tetrahydronaphthalenes | 1999 |
Novel arylsulfonamide derivatives with 5-HT₆/5-HT₇ receptor antagonism targeting behavioral and psychological symptoms of dementia.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Avoidance Learning; Benzoxazoles; Catalepsy; CHO Cells; Cricetulus; Dementia; Dopamine D2 Receptor Antagonists; HEK293 Cells; Humans; Male; Models, Molecular; Motor Activity; Radioligand Assay; Rats, Wistar; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship; Sulfonamides | 2014 |
Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia.
Topics: Animals; Benzamides; Dementia; Dose-Response Relationship, Drug; Drug Partial Agonism; Humans; Indoles; Ligands; Male; Models, Molecular; Molecular Structure; Piperazines; Quinolones; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Serotonin; Structure-Activity Relationship; Swimming | 2015 |
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.
Topics: Amino Alcohols; Animals; Anticonvulsants; Chemistry, Physical; Dose-Response Relationship, Drug; Drug Design; Epilepsy; Male; Mice; Microsomes, Liver; Molecular Structure; Pilocarpine | 2016 |
Tetrahydroprotoberberine alkaloids with dopamine and σ receptor affinity.
Topics: Alkaloids; Berberine; Receptors, Dopamine; Receptors, sigma | 2016 |
Identification of C10 nitrogen-containing aporphines with dopamine D
Topics: Aporphines; Dopamine Agonists; Dose-Response Relationship, Drug; Humans; Ligands; Molecular Docking Simulation; Molecular Structure; Receptors, Dopamine D1; Receptors, Dopamine D5; Structure-Activity Relationship | 2020 |
Synthesis and dopamine receptor pharmacological evaluations on ring C ortho halogenated 1-phenylbenzazepines.
Topics: Benzazepines; Dopamine Antagonists; Dose-Response Relationship, Drug; Halogenation; Molecular Structure; Receptors, Dopamine D1; Structure-Activity Relationship | 2020 |
Structural manipulation of aporphines via C10 nitrogenation leads to the identification of new 5-HT
Topics: Aporphines; Cell Line; Humans; Ligands; Molecular Docking Simulation; Molecular Structure; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship | 2020 |
Aporphines. 58. N-(2-chloroethyl) [8,9-2H]norapomorphine, an irreversible ligand for dopamine receptors: synthesis and application.
Topics: Animals; Aporphines; Binding, Competitive; Corpus Striatum; Dogs; Pituitary Gland, Anterior; Receptors, Dopamine; Spiperone; Swine | 1984 |
Conformational analysis, pharmacophore identification, and comparative molecular field analysis of ligands for the neuromodulatory sigma 3 receptor.
Topics: Animals; Ligands; Models, Molecular; Molecular Conformation; Receptors, sigma; Rodentia; Structure-Activity Relationship; Tetrahydronaphthalenes | 1994 |
Novel potent sigma 1 ligands: N-[omega-(tetralin-1-yl)alkyl]piperidine derivatives.
Topics: Animals; Hippocampus; Ketanserin; Phencyclidine; Piperidines; Rats; Receptors, Phencyclidine; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Receptors, sigma; Spiperone; Structure-Activity Relationship; Tetrahydronaphthalenes | 1996 |
Synthesis and structure-activity relationships of 1-aralkyl-4-benzylpiperidine and 1-aralkyl-4-benzylpiperazine derivatives as potent sigma ligands.
Topics: Animals; Binding Sites; Biochemistry; Cells, Cultured; Drug Evaluation, Preclinical; Guinea Pigs; Humans; Inhibitory Concentration 50; Ligands; Piperazines; Piperidines; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Receptors, Opioid; Receptors, sigma; Serotonin 5-HT1 Receptor Agonists; Sigma-1 Receptor; Structure-Activity Relationship | 2005 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Carrageenan; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Humans; Hyperalgesia; Ligands; Mice; Molecular Structure; Pain; Peritonitis; Quinazolines; Rats; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Stereoisomerism; Structure-Activity Relationship | 2008 |
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de
Topics: Analgesics; Animals; Benzimidazoles; Drug Design; Drug Evaluation, Preclinical; Humans; Microsomes, Liver; Neuralgia; Nociceptin Receptor; Pyrroles; Rats; Receptors, Opioid; Structure-Activity Relationship | 2010 |
Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds.
Topics: Animals; Area Under Curve; Humans; Intestinal Absorption; Ligands; Male; Metabolic Clearance Rate; Models, Chemical; Models, Molecular; Molecular Structure; Protein Binding; Protein Structure, Tertiary; Pyrrolidinones; Radioligand Assay; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT3; Serotonin 5-HT1 Receptor Agonists; Structure-Activity Relationship | 2013 |
Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.
Topics: Acetamides; Allosteric Regulation; Animals; Rats; Rats, Wistar; Receptors, sigma; Sigma-1 Receptor; Stereoisomerism; Structure-Activity Relationship | 2013 |
Shuttle-cargo fusion molecules of transport peptides and the hD2/3 receptor antagonist fallypride: a feasible approach to preserve ligand-receptor binding?
Topics: Amino Acid Sequence; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Biological Transport; Blood-Brain Barrier; Carrier Proteins; Dopamine Antagonists; Humans; Ligands; Models, Molecular; Molecular Docking Simulation; Molecular Sequence Data; Receptors, Dopamine D2; Receptors, Transferrin; Transcytosis | 2014 |
The interactions of bromocriptine and lergotrile with dopamine and alpha-adrenergic receptors.
Topics: Acetonitriles; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Apomorphine; Binding Sites; Brain; Bromocriptine; Butaclamol; Cattle; Cerebral Cortex; Corpus Striatum; Dihydroergotoxine; Dopamine; Ergolines; Haloperidol; In Vitro Techniques; Osmolar Concentration; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Synaptosomes; Tyrosine 3-Monooxygenase | 1977 |
Effects of chronic haloperidol on caudate 3H-spiroperidol binding in lesioned rats.
Topics: Animals; Butaclamol; Butyrophenones; Caudate Nucleus; Cerebral Cortex; Haloperidol; Kainic Acid; Rats; Receptors, Dopamine; Spiperone | 1979 |
Multiple receptors for brain dopamine.
Topics: Animals; Binding, Competitive; Butaclamol; Cattle; Caudate Nucleus; Dihydroergotoxine; Dopamine; Haloperidol; Norepinephrine; Receptors, Dopamine; Spiperone | 1978 |
Effect of morphine, beta-endorphin and leu-enkephalin on 3H-spiroperidol binding to bovine pituitary membranes.
Topics: Animals; Binding Sites; Butaclamol; Butyrophenones; Cattle; Chlorpromazine; Dose-Response Relationship, Drug; Endorphins; Enkephalins; Haloperidol; Membranes; Morphine; Pituitary Gland, Anterior; Spiperone | 1979 |
Binding of 3H-lisuride hydrogen maleate to striatal membranes of rat brain.
Topics: Animals; Apomorphine; Binding, Competitive; Butaclamol; Catecholamines; Corpus Striatum; Dopamine; Ergolines; Haloperidol; Lisuride; Male; Membranes; Methysergide; Phentolamine; Rats | 1979 |
Dopamine receptor binding in vivo: the feasibility of autoradiographic studies.
Topics: Animals; Apomorphine; Autoradiography; Butaclamol; Cerebellum; Cerebral Cortex; Corpus Striatum; Haloperidol; Hippocampus; Male; Rats; Receptors, Dopamine; Spiperone | 1978 |
The binding of haloperidol to human blood platelets and interactions with 5-hydroxytryptamine and dopamine.
Topics: Adult; Binding, Competitive; Blood Platelets; Butaclamol; Dopamine; Female; Haloperidol; Humans; In Vitro Techniques; Male; Serotonin; Time Factors | 1978 |
Induction of c-fos mRNA expression in rat striatum by neuroleptic drugs.
Topics: Animals; Antipsychotic Agents; Butaclamol; Corpus Striatum; DNA-Binding Proteins; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Haloperidol; Male; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fos; Quinpirole; Rats; Rats, Inbred Strains; RNA, Messenger; Stereoisomerism | 1990 |
Regulation and molecular characterization of dopamine D2 receptors in a prolactin-secreting 7315a anterior pituitary tumor.
Topics: Animals; Azides; Blotting, Northern; Butaclamol; Corpus Striatum; Female; Haloperidol; In Vitro Techniques; Kinetics; Neoplasms, Experimental; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred BUF; Receptors, Dopamine; RNA, Messenger; Spiperone | 1990 |
Monoaminergic regulation of proopiomelanocortin messenger RNA concentrations in primary cell cultures of rat hypothalamus.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Animals; Bromocriptine; Butaclamol; Cells, Cultured; Dexamethasone; Dopamine; Embryo, Mammalian; Haloperidol; Hypothalamus; Kinetics; Norepinephrine; Nucleic Acid Hybridization; Pro-Opiomelanocortin; Rats; Rats, Inbred Strains; RNA Probes; RNA, Messenger | 1991 |
The effect of dopamine upon oxidative metabolism of brown fat adipocytes.
Topics: Adipose Tissue, Brown; Adrenergic alpha-Antagonists; Animals; Butaclamol; Dopamine; Fatty Acids, Nonesterified; Female; Glycerol; Haloperidol; In Vitro Techniques; Oxidation-Reduction; Oxygen Consumption; Propranolol; Rats; Rats, Inbred Strains | 1985 |
Effects of dopamine superfusion on the activity of rabbit carotid chemoreceptors in vitro.
Topics: Animals; Butaclamol; Carbon Dioxide; Carotid Body; Chlorpromazine; Dopamine; Haloperidol; Oxygen; Rabbits; Synaptic Transmission | 1985 |
Neural not tubular dopamine increases glomerular filtration rate in perfused rat kidneys.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Benzazepines; Butaclamol; Carbidopa; Catecholamines; Dopamine; Glomerular Filtration Rate; Haloperidol; Kidney; Male; Rats; Sodium; Vascular Resistance | 1986 |
Prenatal neuroleptic exposure alters postnatal striatal cholinergic activity in the rat.
Topics: Animals; Butaclamol; Choline O-Acetyltransferase; Cholinergic Fibers; Corpus Striatum; Dibenzocycloheptenes; Dopamine; Female; Haloperidol; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Muscarinic | 1986 |
Dopamine antagonists reduce spontaneous electrical activity in cultured mammalian neurons from ventral mesencephalon.
Topics: Action Potentials; Animals; Apomorphine; Butaclamol; Cells, Cultured; Dibenzocycloheptenes; Dopamine Antagonists; Fetus; Haloperidol; Membrane Potentials; Mesencephalon; Mice; Mice, Inbred ICR; Neurons; Receptors, Dopamine; Spinal Cord; Spiperone | 1986 |
Kinetic modeling of receptor-ligand binding applied to positron emission tomographic studies with neuroleptic tracers.
Topics: Animals; Antipsychotic Agents; Benperidol; Butaclamol; Cerebellum; Corpus Striatum; Female; Fluorine; Haloperidol; Kinetics; Models, Biological; Papio; Radioisotopes; Receptors, Dopamine; Spiperone; Tomography, Emission-Computed | 1987 |
The relaxing effect of SKF 38393 on the catch contraction of Mytilus smooth muscle.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Appetite Depressants; Benzazepines; Bivalvia; Butaclamol; Cyclic AMP; Haloperidol; In Vitro Techniques; Muscle Contraction; Muscle Proteins; Muscle, Smooth | 1986 |
In vitro characterisation of dopamine receptors in the superior colliculus of the rat.
Topics: Animals; Apomorphine; Binding, Competitive; Butaclamol; Catecholamines; Corpus Striatum; Haloperidol; In Vitro Techniques; Kinetics; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Serotonin; Spiperone; Sulpiride; Superior Colliculi; Synaptosomes | 1987 |
Acute thioridazine stimulates mesolimbic but not nigrostriatal dopamine release: demonstration by in vivo electrochemistry.
Topics: 4-Butyrolactone; Animals; Antipsychotic Agents; Butaclamol; Corpus Striatum; Dopamine; Electrochemistry; Haloperidol; Male; Nucleus Accumbens; Rats; Rats, Inbred Strains; Septal Nuclei; Thioridazine | 1987 |
Thermodynamic analysis of antagonist and agonist interactions with dopamine receptors.
Topics: Animals; Apomorphine; Butaclamol; Caudate Nucleus; Haloperidol; In Vitro Techniques; Microsomes; Receptors, Dopamine; Sheep; Spiperone; Temperature; Thermodynamics | 1988 |
Dopamine receptors on adrenal chromaffin cells modulate calcium uptake and catecholamine release.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenal Glands; Animals; Apomorphine; Butaclamol; Calcium; Calcium Radioisotopes; Catecholamines; Cattle; Cells, Cultured; Chromaffin System; Electric Conductivity; Haloperidol; Ion Channels; Nicotine; Potassium; Receptors, Dopamine; Spiperone; Sulpiride | 1988 |
Dopamine selectively inhibits angiotensin II-induced aldosterone secretion by interacting with D-2 receptors.
Topics: Adrenal Cortex; Aldosterone; Angiotensin II; Animals; Benzazepines; Bromocriptine; Butaclamol; Cyclic AMP; Dopamine; Haloperidol; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1988 |
Immuno-photoaffinity labeling of the D2-dopamine receptor.
Topics: Affinity Labels; Animals; Apomorphine; Azides; Butaclamol; Cattle; Corpus Striatum; Haloperidol; Immunologic Techniques; Kinetics; Molecular Weight; Photochemistry; Receptors, Dopamine; Spiperone | 1988 |
Substitution and antagonism in rats trained to discriminate (+)-N-allylnormetazocine from saline.
Topics: Animals; Binding Sites; Butaclamol; Cyclazocine; Discrimination Learning; Ethylketocyclazocine; Haloperidol; Male; Phenazocine; Rats; Rats, Inbred Strains; Receptors, Neurotransmitter; Receptors, Phencyclidine | 1989 |
Evidence for a model of activation of central sigma systems.
Topics: Animals; Benzazepines; Benzomorphans; Butaclamol; Carbazoles; Dopamine Antagonists; Haloperidol; Kinetics; Male; Models, Biological; Motor Activity; Naltrexone; Narcotic Antagonists; Phenazocine; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, sigma; Sulpiride | 1989 |
The effect of the stereoisomers of butaclamol on neurotensin content in discrete regions of the rat brain.
Topics: Animals; Brain; Butaclamol; Dextroamphetamine; Dibenzocycloheptenes; Haloperidol; Male; Neurotensin; Organ Specificity; Rats; Rats, Inbred Strains; Reference Values; Stereoisomerism; Structure-Activity Relationship | 1988 |
Comparison of three 18F-labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography.
Topics: Animals; Benperidol; Brain; Butaclamol; Butyrophenones; Female; Fluorine; Haloperidol; Isotope Labeling; Male; Papio; Radioisotopes; Rats; Spiperone; Time Factors; Tissue Distribution; Tomography, Emission-Computed | 1985 |
Drug potencies on partially purified brain D2 dopamine receptors.
Topics: Animals; Butaclamol; Chlorpromazine; Corpus Striatum; Dogs; Fluphenazine; Haloperidol; Isoelectric Focusing; Receptors, Dopamine; Receptors, Dopamine D2; Spiperone; Stereoisomerism; Time Factors | 1985 |
Amphetamine stimulation of glutaminase is blocked by neuroleptics.
Topics: Amphetamine; Animals; Antipsychotic Agents; Brain; Butaclamol; Chlorpromazine; Clozapine; Enzyme Activation; Glutaminase; Haloperidol; In Vitro Techniques; Male; Rats; Rats, Inbred Strains; Stereoisomerism | 1985 |
Direct effect of neuroleptics on glutamate release.
Topics: Amygdala; Animals; Antipsychotic Agents; Atropine; Avoidance Learning; Butaclamol; Calcium; Chlorpromazine; Clozapine; Glutamates; Glutamic Acid; Glutamine; Haloperidol; In Vitro Techniques; Male; Rats; Synaptosomes | 1984 |
Dopaminergic stimulation of prolactin release.
Topics: Animals; Apomorphine; Bromocriptine; Butaclamol; Cells, Cultured; Dopamine; Haloperidol; Male; Pituitary Gland; Prolactin; Rats; Receptors, Dopamine | 1980 |
Effects of chronic and acute treatment of antipsychotic drugs on calmodulin release from rat striatal membranes.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Butaclamol; Calcium-Binding Proteins; Calmodulin; Corpus Striatum; Dopamine; Haloperidol; Male; Membranes; Rats; Stereoisomerism | 1980 |
Antipsychotic drug effects on dopamine and serotonin receptors: in vitro binding and in vivo turnover studies.
Topics: Animals; Antipsychotic Agents; Brain; Butaclamol; Catalepsy; Dopamine; Fluphenazine; Haloperidol; Humans; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Serotonin; Spiperone | 1981 |
Characterization of catecholamine binding sites in the rat brain.
Topics: Animals; Brain; Butaclamol; Catecholamines; Corpus Striatum; Dihydroalprenolol; Dihydroergotoxine; Haloperidol; In Vitro Techniques; Male; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Spiperone | 1981 |
Interaction of opiates with dopamine receptors: receptor binding and behavioral assays.
Topics: Animals; Apomorphine; Binding, Competitive; Brain; Butaclamol; Dibenzocycloheptenes; Haloperidol; Kinetics; Male; Methadone; Morphine; Naloxone; Rats; Receptors, Dopamine; Spiperone | 1982 |
Neuroleptic-induced seizures. An in vitro technique for assessing relative risk.
Topics: Animals; Antipsychotic Agents; Butaclamol; Chlorpromazine; Culture Techniques; Dose-Response Relationship, Drug; Fluphenazine; Guinea Pigs; Haloperidol; Hippocampus; Male; Molindone; Pimozide; Seizures; Thioridazine | 1982 |
Calcium alters the sensitivity of intact horizontal cells to dopamine antagonists.
Topics: Animals; Butaclamol; Calcium; Carps; Cyclic AMP; Dopamine; Dopamine Antagonists; Flupenthixol; Glutamates; Haloperidol; Retina | 1982 |
Effects of vasoactive intestinal peptide and other peptides on cyclic AMP accumulation in intact pieces and isolated horizontal cells of the teleost retina.
Topics: Amino Acid Sequence; Animals; Butaclamol; Cyclic AMP; Dopamine; Fishes; Flupenthixol; Glucagon; Haloperidol; Retina; Secretin; Vasoactive Intestinal Peptide | 1983 |
The effects of denervation and chronic haloperidol treatment on neostriatal dopamine receptor density are not additive in the rat.
Topics: Animals; Apomorphine; Butaclamol; Corpus Striatum; Drug Interactions; Haloperidol; Hydroxydopamines; Male; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Rotation; Spiperone | 1984 |
[3H]spiperone binding in the nigrostriatal system in human brain.
Topics: Aged; Apomorphine; Binding, Competitive; Butaclamol; Butyrophenones; Caudate Nucleus; Cinanserin; Corpus Striatum; Domperidone; Female; Haloperidol; Humans; In Vitro Techniques; Kinetics; Male; Nerve Endings; Phentolamine; Postmortem Changes; Putamen; Spiperone; Substantia Nigra; Sulpiride; Time Factors | 1984 |
Dopamine modulation of active ion transport in rabbit corneal epithelium.
Topics: Animals; Biological Transport, Active; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Butaclamol; Chlorides; Cornea; Dopamine; Electric Conductivity; Epithelium; Haloperidol; Rabbits; Sympathectomy; Timolol | 1984 |
High- and low-affinity states of striatal D2 receptors are not affected by 6-hydroxydopamine or chronic haloperidol treatment.
Topics: Animals; Apomorphine; Butaclamol; Cinanserin; Corpus Striatum; Dopamine; Guanylyl Imidodiphosphate; Haloperidol; Hydroxydopamines; Male; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone | 1984 |
D4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary cells.
Topics: Amiloride; Animals; Arachidonic Acid; Base Sequence; Butaclamol; CHO Cells; Cloning, Molecular; Clozapine; Cricetinae; Cyclic AMP; DNA; Dopamine; Dopamine Antagonists; Ergolines; Genes, Synthetic; Haloperidol; Humans; Kinetics; Molecular Sequence Data; Pertussis Toxin; Protein Kinase C; Quinpirole; Raclopride; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D4; Recombinant Proteins; Salicylamides; Signal Transduction; Sodium-Hydrogen Exchangers; Transfection; Virulence Factors, Bordetella | 1994 |
Pharmacological characterisation of high affinity [35S]GTP gamma S binding in membranes from CHO-K1 cells stably expressing rat D2(short) dopamine receptors.
Topics: Animals; Butaclamol; Cell Membrane; CHO Cells; Cricetinae; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Kinetics; Rats; Receptors, Dopamine D2; Recombinant Proteins; Spiperone; Stereoisomerism; Sulfur Radioisotopes | 1995 |
Myocardial accumulation of a dopamine D2 receptor-binding radioligand, 2'-iodospiperone.
Topics: Animals; Butaclamol; Haloperidol; Heart; Injections, Intravenous; Iodine Radioisotopes; Male; Mice; Myocardium; Radionuclide Imaging; Rats; Receptors, Dopamine D2; Spiperone; Tissue Distribution | 1993 |
Pharmacological characterization and autoradiographic localization of dopamine receptors in the rat adrenal medulla.
Topics: Adrenal Medulla; Animals; Autoradiography; Benzazepines; Butaclamol; Corpus Striatum; Haloperidol; Male; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Spiperone; Sulpiride | 1996 |
[18F]haloperidol binding in baboon brain in vivo.
Topics: Animals; Brain; Butaclamol; Dopamine Antagonists; Fluorine Radioisotopes; Haloperidol; Isotope Labeling; Papio; Receptors, Dopamine D2; Tomography, Emission-Computed | 1996 |
Effects of dopamine and dopamine-active compounds on oxytocin and vasopressin production in rat neurohypophyseal tissue cultures.
Topics: Animals; Apomorphine; Butaclamol; Chlorpromazine; Culture Techniques; Dopamine; Dopamine Agonists; Dopamine Antagonists; Drug Synergism; Haloperidol; Male; Neuroglia; Oxytocin; Pituitary Gland; Rats; Rats, Wistar; Sulpiride; Vasopressins | 2001 |
Mechanisms of inverse agonism of antipsychotic drugs at the D(2) dopamine receptor: use of a mutant D(2) dopamine receptor that adopts the activated conformation.
Topics: 1-Methyl-3-isobutylxanthine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Apomorphine; Binding, Competitive; Bromocriptine; Butaclamol; Chlorpromazine; CHO Cells; Clozapine; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; GTP-Binding Proteins; Haloperidol; Humans; Macromolecular Substances; Mutagenesis, Site-Directed; Phenethylamines; Piperidines; Protein Binding; Protein Conformation; Radioligand Assay; Receptors, Dopamine D2; Recombinant Fusion Proteins; Sodium; Spiperone; Structure-Activity Relationship; Sulpiride; Transfection; Tyramine | 2001 |
Real-time analysis of dopamine: antagonist interactions at recombinant human D2long receptor upon modulation of its activation state.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Alternative Splicing; Animals; Binding, Competitive; Butaclamol; Calcium; CHO Cells; Clozapine; Cricetinae; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Genotype; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Humans; Lisuride; Mutation; Plasmids; Receptors, Dopamine; Receptors, Dopamine D2; Recombinant Proteins; Sulfur Radioisotopes; Time Factors | 2001 |
Decreased [(3)H]spiperone binding in the anterior cingulate cortex of schizophrenia patients: an autoradiographic study.
Topics: Adult; Aged; Antipsychotic Agents; Binding Sites; Binding, Competitive; Butaclamol; Down-Regulation; Gyrus Cinguli; Haloperidol; Humans; Mianserin; Middle Aged; Neurons; Neurotransmitter Agents; Radioligand Assay; Receptors, Neurotransmitter; Risperidone; Schizophrenia; Spiperone; Tritium | 2002 |
Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation.
Topics: Animals; Anisoles; Antipsychotic Agents; Benzazepines; Butaclamol; Caspase Inhibitors; Cell Death; Cells, Cultured; Chlorpromazine; Clozapine; Domperidone; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Ginkgo biloba; Haloperidol; Hippocampus; Indans; Isoxazoles; Neurons; Neuroprotective Agents; Peptides; Piperidines; Plant Extracts; Propylamines; Raclopride; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; Remoxipride; Risperidone; Sulpiride | 2006 |